American Bio Medica Corporation
ABMC
$0.0001
$0.000.00%
OTC PK
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 693.38% | -0.96% | 21.50% | -5.54% | -16.62% |
| Total Depreciation and Amortization | -38.46% | 8.33% | -7.69% | 0.00% | -13.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9,966.67% | -425.00% | 77.78% | -228.57% | -97.64% |
| Change in Net Operating Assets | 51.75% | -223.81% | -31.25% | -0.88% | 377.87% |
| Cash from Operations | 40.59% | -714.67% | -8.70% | -430.77% | -108.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -62.96% | 88.55% | -0.83% | -21.86% | -5.52% |
| Total Debt Repaid | -150.00% | 85.45% | 10.42% | 43.88% | 18.96% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -76.38% | 665.06% | 53.70% | 163.53% | 1.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 41.67% | 200.00% | 153.33% | 84.69% | -232.43% |